Preferred Label : KRAS G12D Degrader ASP4396;
NCIt definition : A targeted protein degrader (TPD) of the oncogenic KRAS substitution mutation G12D,
with potential antineoplastic activity. ASP4396 is comprised of an E3 ubiquitin ligase-binding
moiety conjugated, via a linker, to a KRAS G12D-binding moiety. Upon administration,
the KRAS G12D-targeting moiety of KRAS G12D degrader ASP4396 specifically targets
and binds to KRAS G12D mutated protein and the E3 ligase-binding moiety targets and
binds to the E3 ubiquitin ligase, thereby forming a ternary complex. This induces
E3 ligase ubiquitination and proteasome-mediated degradation of KRAS G12D mutated
protein. This prevents KRAS G12D-mediated signaling and activation of downstream survival
pathways. This leads to an inhibition of the growth of tumor cells that overexpress
KRAS G12D. KRAS, a member of the RAS family of oncogenes, serves an important role
in cell signaling, division and differentiation. Mutations of KRAS may induce constitutive
signal transduction leading to tumor cell proliferation, invasion, and metastasis.;
Molecule name : ASP-4396; ASP 4396;
Origin ID : C212079;
concept_is_in_subset
- has_target
